Comparing Profitability of these two stocks: Baker Hughes, a GE company (BHGE), Agile Therapeutics, Inc. (AGRX)

The shares of Baker Hughes, a GE company (NYSE:BHGE) and Agile Therapeutics, Inc. (NASDAQ:AGRX) were among the active stocks of the last trading sessions. Baker Hughes, a GE company (NYSE:BHGE) declined to -3.95% closing at the price of $30.66 whereas the shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) declined -6.98% with the decrease of -0.05 points closing at the price of $0.61. Baker Hughes, a GE company has currently decrease -5.86% in its stock over the period of 6-months while its rival Agile Therapeutics, Inc. subtracted -79.32% in the previous 6-months.

Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.

Returns and Profitability

Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.

The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Baker Hughes, a GE company (NYSE:BHGE) is -0.7% while the ROI of Agile Therapeutics, Inc. (NASDAQ:AGRX) is 0%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, BHGE’s EBITDA Margin is 15.97 whereas AGRX’s is 0.06.

Both the profitability ratios suggest a mixed sentiment for Baker Hughes, a GE company (NYSE:BHGE) and Agile Therapeutics, Inc. (NASDAQ:AGRX).

EPS & Surprise Factor

Baker Hughes, a GE company (NYSE:BHGE) reported $0.1/share EPS for the previous quarter where analysts were predicting an EPS to be $0.14/share Thus lagging the analyst Estimates with a Surprise Factor of -28.6 Percent. While, Agile Therapeutics, Inc. (NASDAQ:AGRX) reported EPS of $-0.16/share in the last quarter. The analysts projected EPS of $-0.17/share depicting a Surprise of 5.9 Percent.

Taking a look at Earnings per Share, Agile Therapeutics, Inc. tends to be beating the analyst estimates more than Baker Hughes, a GE company. so AGRX is more profitable than BHGE.

Technical Analysis of Baker Hughes, a GE company & Agile Therapeutics, Inc.

Moving average convergence divergence (MACD) shows that Baker Hughes, a GE company (NYSE:BHGE) is on a PRICE RELATIVITY trend While Agile Therapeutics, Inc. (NASDAQ:AGRX) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Baker Hughes, a GE company was in BEARISH territory and Agile Therapeutics, Inc. was in BULLISH territory.

BHGE’s current statistics gauge that the stock candle is BEARISH with MEDIUM volatility. While AGRX’s candle is BEARISH with HIGH.

EPS Growth Rate: BHGE’s 0% versus AGRX’s 0%

Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Baker Hughes, a GE company (NYSE:BHGE) is predicted at 0% while Agile Therapeutics, Inc. (NASDAQ:AGRX) stands at 0%. These numbers suggest that AGRX is more suitable investment in terms of EPS growth rate.

Financial Risk and Liquidity Concerns

The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of BHGE stands at 1.9 while AGRX is at 2.2 whereas the debt ratio of the prior is 0.2 while the debt ratio of the later is 0.29.

The values of the both ratios suggest that AGRX is more suitable investment when the liquidity and risk is the main concern.

Analyst Recommendations

While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.2 for BHGE and 2.4 for AGRX which means BHGE has Hold rating whereas AGRX has Hold rating.

Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for BHGE is $38.32 which is 19.99% of its current price while AGRX has price target of 6 which is 89.83% of its current price.

Valuation Ratios

Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.

BHGE currently has price to earning P/E ratio of 0 whereas AGRX has 0 while the forward P/E ratio for the prior stands at 20.7 and for the later it depicts the value of 0.

The price to Book P/B for BHGE is 0.35, Price to Sale is at 1.55 and for AGRX these ratios stand at 0.79 and 0.